| 前收市價 | 無 |
| 開市 | 無 |
| 買盤 | 無 |
| 賣出價 | 無 |
| 拍板 | 無 |
| 到期日 | 無 |
| 今日波幅 | 無 - 無 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
ZacksPacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.
Insider MonkeyPacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript May 7, 2024 Pacira BioSciences, Inc. misses on earnings expectations. Reported EPS is $0.62 EPS, expectations were $0.64. PCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
Insider MonkeyAggressive Stock Portfolio: 13 Stocks Picked by Analysts
In this article, we will take a look at aggressive stock portfolio: 13 stocks picked by analysts. To skip our analysis of the recent market activity, you can go directly to see the Aggressive Stock Portfolio: 5 Stocks Picked by Analysts. By definition, aggressive stocks are ones that offer higher returns than conservative and relatively […]
